ES2068952T3 - Nuevas n-hidroxi-n-metilureas vinilogas ciclicas utiles como inhibidores de 5-lipoxigenasa. - Google Patents

Nuevas n-hidroxi-n-metilureas vinilogas ciclicas utiles como inhibidores de 5-lipoxigenasa.

Info

Publication number
ES2068952T3
ES2068952T3 ES90113677T ES90113677T ES2068952T3 ES 2068952 T3 ES2068952 T3 ES 2068952T3 ES 90113677 T ES90113677 T ES 90113677T ES 90113677 T ES90113677 T ES 90113677T ES 2068952 T3 ES2068952 T3 ES 2068952T3
Authority
ES
Spain
Prior art keywords
hydroxy
useful
vinylogues
new
methylene cyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90113677T
Other languages
English (en)
Inventor
Gary A Flynn
Douglas W Beight
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2068952T3 publication Critical patent/ES2068952T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Abstract

SON UTILES PARA EL TRATAMIENTO DE LAS CONDICIONES MEDIALES DE LA LEUCOTRIENA , COMO EL ASMA Y LA ARTRITIS REUMATOIDE.
ES90113677T 1989-07-17 1990-07-17 Nuevas n-hidroxi-n-metilureas vinilogas ciclicas utiles como inhibidores de 5-lipoxigenasa. Expired - Lifetime ES2068952T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/380,937 US5026861A (en) 1989-07-17 1989-07-17 Substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-ones

Publications (1)

Publication Number Publication Date
ES2068952T3 true ES2068952T3 (es) 1995-05-01

Family

ID=23503027

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90113677T Expired - Lifetime ES2068952T3 (es) 1989-07-17 1990-07-17 Nuevas n-hidroxi-n-metilureas vinilogas ciclicas utiles como inhibidores de 5-lipoxigenasa.

Country Status (10)

Country Link
US (1) US5026861A (es)
EP (1) EP0409163B1 (es)
JP (1) JP2879464B2 (es)
AT (1) ATE115948T1 (es)
AU (1) AU627339B2 (es)
CA (1) CA2021340C (es)
DE (1) DE69015270T2 (es)
DK (1) DK0409163T3 (es)
ES (1) ES2068952T3 (es)
GR (1) GR3015458T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109010A (en) * 1989-07-17 1992-04-28 Merrell Dow Pharmaceuticals Inc. Dibenzofuranyl substituted 1,5-dihydro-4-(N-methylhydroxylamino)-2H-pyrrol-2-ones
DE4213931A1 (de) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4213919A1 (de) * 1992-04-28 1993-11-04 Thomae Gmbh Dr K Cyclische iminoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US7937897B2 (en) * 2006-01-25 2011-05-10 Yusenkaisha Japan Isusyc Dome-shaped shelter
US8703952B2 (en) 2008-12-12 2014-04-22 Wista Laboratories Ltd. Synthesis of 9-(arylalkyl)-1,2,3,4-tetrahydro-γ-carboline and analogues and intermediates
KR101523868B1 (ko) 2011-02-21 2015-05-28 캐논 가부시끼가이샤 열처리 장치 및 토너 제조 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0623194B2 (ja) * 1985-03-23 1994-03-30 鐘淵化学工業株式会社 新規ラクタム誘導体及び抗炎症剤
JPS63115859A (ja) * 1986-10-31 1988-05-20 Eisai Co Ltd ２−ピロリドン誘導体を含有する抗炎症剤

Also Published As

Publication number Publication date
AU5900190A (en) 1991-01-17
CA2021340C (en) 2001-01-23
DK0409163T3 (da) 1995-02-20
CA2021340A1 (en) 1991-01-18
US5026861A (en) 1991-06-25
JPH0352858A (ja) 1991-03-07
JP2879464B2 (ja) 1999-04-05
DE69015270D1 (de) 1995-02-02
EP0409163B1 (en) 1994-12-21
ATE115948T1 (de) 1995-01-15
EP0409163A3 (en) 1991-03-20
AU627339B2 (en) 1992-08-20
EP0409163A2 (en) 1991-01-23
GR3015458T3 (en) 1995-06-30
DE69015270T2 (de) 1995-06-08

Similar Documents

Publication Publication Date Title
ES8602768A1 (es) Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas.
DE68928368T2 (de) Rekombinante DNA, sie enthaltendes Bakterium der Gattung Pseudomonas und ihre Verwendung zur Herstellung von Lipase
DE3878994D1 (de) Kovalente kupplung von antikoagulantien und dergleichen an biomaterialien.
DE59000652D1 (de) Verwendung von umsetzungsprodukten von alkenylspirobislactonen und aminen als paraffindispergatoren.
DE3888274T2 (de) Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
DE69007823T2 (de) Behandeltes Siliziumdioxid zur Verstärkung von Silikonelastomer.
DE69218621D1 (de) Endlosformular und vorrichtung zum herstellen von briefbogen davon
ATA164588A (de) Einrichtung zur kompensation der hochschlagenergie von faustfeuerwaffen
DE58906363D1 (de) Verfahren zur Überführung von festen, weitgehend wasserfreien Abfallstoffen in Glasform sowie Vorrichtung zur Durchführung des Verfahrens.
DE3888146T2 (de) Modifizierte Polytetrafluoräthylenharze und damit hergestellte Zusammensetzungen.
DE69022553D1 (de) Vorrichtung zum Unterdrücken von Spannungsschwankungen und Oberschwingungen.
ES2068952T3 (es) Nuevas n-hidroxi-n-metilureas vinilogas ciclicas utiles como inhibidores de 5-lipoxigenasa.
ES2135477T3 (es) Proceso de produccion de (s)-3-amino-1-pirrolidinas sustituidas.
DE69007449D1 (de) Verfahren zur Herstellung von Leistungsmos- und Halbleiteranordnungen und damit hergestellten Anordnungen.
DK67683A (da) Fremgangsmaade til fremstilling af 2,3-diaryl-5-halogen-thio-phener
DE69012298D1 (de) Heizen von Lagern und dergleichen.
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
DE3679781D1 (de) Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung.
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
DE69412300D1 (de) Vorrichtung zur Herstellung von Glasvorformen
DE69424768D1 (de) Polydioxolanhochmolekulargewichte und herstellungsverfahren
DE68928763T2 (de) Verfahren zur Herstellung von isolierten vertikalbipolaren und JFET-Transistoren und entsprechender IC
FI893777A (fi) Fyto- och zoosteroler samt derivat daerav med foerbaettrad vattenloeslighet.
DE3785930D1 (de) Verfahren und vorrichtung schnellen rehydratation von gemuesen und dergleichen.
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 409163

Country of ref document: ES